United States: 21st Century Cures: Health Information Technology And Digital Health Tool Provisions In Title IV

Summary

The 21st Century Cures Act encourages biomedical research investment and facilitates innovation review and approval processes, but also serves as a vehicle for a wide variety of other health-related measures, including provisions relating to health information technology (HIT) and related digital health initiatives. President Barack Obama has expressed support for the Cures legislation and is expected to sign the bill this month. This On the Subject summarizes the HIT and digital health tool provisions in title IV of the new legislation. Our continuing coverage of the 21st Century Cares Act addresses additional titles and provisions.

In Depth

On December 7, 2016, the US Congress approved the 21st Century Cures Act (Cures legislation), which is intended to accelerate the "discovery, development and delivery" of medical therapies by encouraging public and private biomedical research investment, facilitating innovation review and approval processes, and continuing to invest and modernize the delivery of health care. The massive bill, however, also served as a vehicle for a variety of other health-related measures, including provisions relating to health information technology (HIT) and related digital health initiatives.  President Barack Obama has expressed support for the Cures legislation and is expected to sign the bill this month.

This On the Subject summarizes the HIT provisions in title IV of the new legislation. Other titles and provisions will be examined through other On the Subject articles.

Overview of the Health Information Technology Provisions in the Cures Legislation

The HIT provisions of the Cures legislation in general seek to

  • Reduce administrative and regulatory burdens associated with providers' use of electronic health records (EHRs)
  • Advance interoperability
  • Promote standards for HIT
  • Curb information blocking
  • Improve patient care and access to health information in EHRs 

Why These Provisions Matter

As public and private payers increasingly move from fee-for-service payments to value-based payment models, with a focus on maximizing health outcomes, population health improvement, and patient engagement, HIT—including EHRs and digital health tools—will be increasingly relied upon to collect clinical data, measure quality and cost effectiveness; assure continuity of care between patients and providers in different locations; and develop evidence-based clinical care guidelines. Further, newly implemented government programs like the Quality Payment Program will increasingly require clinicians and hospitals to use certified EHR technology (CEHRT) that meets certification guidelines specified by the Office of the National Coordinator for Health Information Technology (ONC) of the US Department of Health and Human Services (HHS). The continued evolution of these certification guidelines will also influence the development of digital health tools that are designed to interface or otherwise interact with CEHRT and assist providers to succeed under value-based payment models.

Congressman Tom Price (R-GA), a physician and a strong advocate for reducing burdens associated with the use of EHRs by providers, has been nominated to serve as HHS secretary in the administration of President-elect Donald Trump. Should Congressman Price be confirmed by the Senate, industry can likely expect HHS to use the new authority provided to it under the Cures legislation to reduce requirements of the Meaningful Use and Advancing Care Information programs, electronic clinical quality measure reporting requirements and other federal requirements relating to HIT that are perceived to make providers less efficient without improving quality or reducing costs. The new HHS secretary, however, will face competing pressures to leverage the expansion of HIT adoption and quality measure reporting to incentivize high-quality care at lower Medicare program costs.

What Is Required by These Cures Legislation Provisions

Reduction of Burdens ‒ In response to clinician and hospital concerns about the regulatory and administrative burdens associated with EHR technology

  • The HHS secretary is required within one year of enactment to develop with public comment from providers, suppliers, payers, technology developers and others a strategy and recommendations to reduce regulatory or administrative burdens related to the use of EHRs; this strategy must prioritize the Medicare and Medicaid EHR Incentive Programs, HIT certification, the Merit-based Incentive Payment System, the Hospital Value-Based Purchasing Program,  Alternative Payment Models, and other value-based payment programs that the HHS secretary determines are appropriate; 
  • Physicians may delegate EHR documentation requirements to unlicensed assistants, or "scribes" (to the extent permitted by state law), provided the physician signs and verifies the documentation;
  • The HHS secretary must encourage, keep or recognize voluntary certification of HIT for use in sites of services and medical specialties for which no certified technology is currently available, with the goal of making EHR certification more relevant and useful for those who use such EHRs. 
  • The HHS secretary must report to the new HIT Advisory Committee statistics on attestation of Meaningful Use under the Medicare and Medicaid EHR Incentive Programs to assist in informing standards adoption and related practices. The statistics must include, to the extent practicable, the number of providers who did not meet the minimum criteria necessary to attest, and must be made publically available on the HHS website;
  • Authorizes $15 million to award grants, contracts or agreements to independent entities on a competitive basis to develop a required CEHRT reporting system to address provider concerns that CEHRT technology does not always work as intended. As a condition of certification and attestation, CEHRT would be required to report measures developed by the independent entity on attributes that include
    • Security
    • User-centered design
    • Interoperability
    • Testing in real-world conditions

This provision aims to create an unbiased reporting system on EHR product usability, interoperability and security to assist providers in choosing product. This reporting system replaces a proposed "Star Rating" plan for EHR technology found in an earlier version of the legislation. 

Advancement of Interoperability ‒ In response to lawmakers' and stakeholders' concerns that while the Health Information Technology for Economic and Clinical Health Act (HITECH) increased the adoption by clinicians and hospitals of electronic health records, it did not sufficiently move the national needle on interoperability, the Cures legislation seeks to advance interoperability through

  • Creating a definition for "interoperability" as HIT that
    • Enables the secure exchange of electronic health information with, and use of electronic health information from, other HIT without special effort on the part of the user
    • Allows for complete access, exchange and use of all electronically accessible health information for authorized use under applicable state or federal law
    • Does not constitute information blocking as defined in the Cures legislation
  • Replacing the HIT Policy and Standards Committees with a new HIT Advisory Committee. This new committee will consist of at least 25 members, eight of whom shall be appointed by Congress, three appointed by the HHS secretary and the remainder appointed by the comptroller general of the US Government Accountability Office (GAO). Specific health sectors must be represented on the committee. This new federal advisory committee will address, in general, issues related to interoperability and privacy and security of health information and will also engage stakeholders to identify priorities for standards adoption.  The Cures legislation provides additional direction on priority target areas on which the committee shall make recommendations. These directives are highly similar to those provided to the predecessor HIT Policy and Standards Committee in HITECH. This reiteration of areas for consideration likely signals that lawmakers believe that many of the objectives set forth in HITECH have not yet been fully achieved.

    One new priority area is patient matching, which relates to the unfulfilled directive to further interoperability between EHR systems. Specifically, the Cures legislation requires the new HIT Advisory Committee to make recommendations for "technology that provides accurate patient information for the correct patient, including exchanging such information, and avoids the duplication of patient records." This directive and the call for a GAO study on patient matching indicates that policy makers recognize the importance of accurately identifying patients for electronic exchange of health information among providers in different organization and locations as well as for patient safety.
  • Tasking ONC to create a process by which the public could submit complaints that HIT products or developers are not interoperable or engage in information blocking. 
  • Directing ONC to, within six months of enactment, convene stakeholders to develop or support (within 12 months of convening) a trusted exchange framework for trust policies and practices and for a common agreement for exchange between health information networks. ONC and the National Institute of Standards and Technology are to provide technical assistance on developing this trusted exchange framework and common agreement. A process will be established through rulemaking by which health information networks may voluntarily adopt the framework and common agreement. Federal agencies may by contracting or entering into agreements with health information exchange networks that require such networks to adopt the trusted exchange framework and common agreement.  

Promotion of Standards – Lawmakers have increasingly recognized that stronger leadership is needed to ensure the consistent implementation and use of common standards. Accordingly, the Cures legislation requires the ONC to, not later than six months after the date on which the HIT Advisory Committee first meets, convene the HIT Advisory Committee to

  • Enhance the use of common standards with deference given to standards published by private standards development organizations and voluntary consensus-based standards bodies.
  • Identify priority use cases for HIT, focusing on use cases relating to
    • The implementation of Medicare's EHR Incentive Program, the Merit-based Incentive Payment System, Alternative Payment Models, the Hospital Value-Based Purchasing Program and any other value-based payment program determined appropriate by the HHS secretary
    • Quality of patient care
    • Public health
    • Clinical research
    • Privacy and security of electronic health information
    • Innovation in the field of HIT
    • Patient safety
    • Usability of health information technology
    • Individuals' access to electronic health information
  • Identify existing standards and implementation specifications that support such use cases.
  • Publish a report summarizing the findings of the analysis and make appropriate recommendations.
  • Evaluate the need for a core set of common data elements and associate value sets to enhance the ability of CEHRT to capture, use and exchange structured electronic health information.

Starting five years after the enactment of the Cures legislation, and every three years thereafter, the ONC must convene stakeholders to review the existing set of adopted standards and implementation specifications and make recommendations for maintaining or phasing out such standards and implementation specifications.

Combatting Information Blocking The Cures legislation builds on the April 2015 ONC Report to Congress on Health Information Blocking and the voluntary ONC interoperability pledges signed earlier this year by companies that provide at least 90 percent of EHRs used by hospitals, and takes even stronger steps to combat information blocking by

  • Defining "information blocking" as a practice, except as required by law or allowed by the HHS secretary pursuant to rulemaking, that
    • Is likely to interfere with, prevent or materially discourage access, exchange or use of electronic health information
    • If conducted by an HIT developer, exchange or network, such entity knows or should know that such practice is likely to interfere with, prevent or materially discourage the access, exchange or use of electronic health information
    • If conducted by a health care provider, such provider knows that such practice is unreasonable and is likely to interfere with, prevent or materially discourage access, exchange or use of electronic health information
  • Establishing that information blocking practices may include
    • Practices that restrict authorized access, exchange or use of such information for treatment and other permitted purposes under such applicable law, including transitions between certified HIT systems
    • Implementing HIT in nonstandard ways that are likely to substantially increase the complexity or burden of accessing, exchanging or using electronic health information
    • Implementing HIT in ways that are likely to
      • Restrict access, exchange or use of electronic health information with respect to exporting complete information sets or in transitioning between HIT systems
      • Lead to fraud, waste or abuse, or impede innovations and advancements in health information access, exchange and use, including care delivery enabled by HIT
  • Establishing new civil monetary penalties of up to $1 million per information blocking violation, including false attestations, that would be applicable to HIT developers, health information exchanges and networks. In contrast, provider penalties will be determined through notice and comment rulemaking. Importantly, for enforcement purposes, information blocking does not include any practice or conduct occurring prior to the date that is 30 days after enactment 

Improving Patient Care and Improving Patient Access to Their Health Information in EHRs

  • Requires the GAO to conduct two studies
    • A study on patient matching within two years of enactment. In calling for this study, lawmakers recognize that, with the increasing use of EHRs and the push toward interoperability, identifying accurately a single individual represented in multiple databases of different provider, payer and clearinghouse organizations is increasingly important for facilitating health information exchange and ensuring patient safety   
    • A study on patient access to their own health information, including barriers to patient access  
  • Enables developers of HIT to participate in discussions with patient safety organizations without fear of liability risk in order to help improve the safety of HIT products for patients. Within four years after the date of enactment, the HHS secretary must submit to Congress a report concerning the best practices and current trends voluntarily provided, without identifying individual providers or developers
  • Requires CEHRT to be capable of transmitting data to, and receiving data from clinician-led clinical data registries

Action Steps for Providers and Developers of HIT and Digital Tools

Providers and Developers of HIT and Digital Tools Should

  • Review the definition of information blocking and take measures necessary to avoid engaging in practices that may constitute information blocking as defined in the new statute.
  • Review applicable state laws that permit physician delegation to scribes to determine if the new federal flexibility applies.
  • Assess potential interest in seeking representation on the new HIT Advisory Committee, either directly or through an association or other group (note that it is unclear how quickly after enactment ONC will form the HIT Advisory Committee, as a timeline for the transition from the HIT Policy Committee and the HIT Standards Committee to the new HIT Advisory Committee is not specified).
  • Assess their implementation of HIT standards to determine the extent to which different standards and inconsistent implementation of the same standards may be prevalent.
  • Be aware that changes to existing government requirements relating to EHRs are likely forthcoming.

Providers Should

  • Assess their unique regulatory environment to provide input on the forthcoming HHS efforts to reduce regulatory burdens.
  • Determine whether their sites of service or specialties would benefit from CEHRT certified to meet their sites' or specialties' unique needs.

Developers of HIT and Digital Tools Should

  • Consider participating in stakeholder outreach efforts to advise ONC on
    • The establishment of a trusted exchange framework and common agreement
    • Criteria and measures for the new CEHRT reporting system
    • The HIT Advisory Committee's review of the existing set of adopted standards and implementation specifications every three years
  • Adapt HIT development and testing strategies based on the criteria and measures established by the independent entity selected by ONC.
  • Consider opportunities to partner with clinician-led organizations or professional societies to develop clinician-led clinical data registries.
  • Keep abreast of new HIT requirements to inform the development of digital tools.
  • Evaluate how best to work with patient safety organizations to promote shared learning to improve HIT safety now that privilege and confidentiality protection has been extended to HIT developers.

21st Century Cures: Health Information Technology and Digital Health Tool Provisions in Title IV

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Similar Articles
Relevancy Powered by MondaqAI
 
In association with
Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions